US stocks buck weak European lead, ASX futures up

Published 15-JUL-2020 09:15 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

ASX futures have lifted ahead of trade as global equity markets rebounded late on Tuesday, buoyed by a surge in cyclical stocks on Wall Street. The Dow Jones jumped over 2% after Monday’s slump, while safe-haven gold prices cemented gains above $1,800 an ounce.

Technology shares initially sold off getting slammed during European trade, while energy, industrial and financial stocks rose. However, the Nasdaq played catch up and ended the day firmly higher as well as investors remain confident about the prospects of the world economy.

ASX futures trade 28 points higher at 8am in Sydney pointing to a day in the black for the local share market.

Yesterday the ASX fell along with most Asian markets after a late-afternoon fall on Wall Street on Monday. The ASX 200 ended the session 0.6% or 36.4 points lower to close at 5,941.1 points. The Small Ordinaries Index of mid-caps eased 1.3% to 2,591.3 points.

European stocks fall, US data mixed

The S&P 500 gained 1.34%, and the Nasdaq Composite added 0.94%, despite early losses. Core inflation remains well under the Federal Reserve’s target of 2%, sending Treasury yields lower.

Despite geopolitical tensions and California’s economy shutting down once again, cyclical stocks rallied.

Earlier in the day, European shares fell across the board after a decline in Asian markets. The broad STOXX Europe 600 index fell 0.84% weighed down by the German DAX, which fell 0.8% in Frankfurt. The FTSE 100 staged a late rally and managed to just finish in the black, up 0.06%.

In Asia, the Hang Seng fell and so did the Nikkei, down 1.14% and 0.87% respectively. Chinese shares drifted lower as well on the back of the tremendous stock market rally. The Shanghai Composite closed down 0.83%.

The MSCI World Index rose 0.53% to 543.54, driven by a rebounding Wall Street.

On the commodities front, oil futures rebounded after an early session slump. Brent crude settled up 18 cents at U$42.90 a barrel. US crude rose 19 cents to settle at U$40.29 a barrel.

Gold prices consolidated over US$1,800 an ounce as the gold rally appears to be far from over.

Iron ore traded +1.3% higher to $US112.48 a tonne.

Political tensions remain elevated between Washington and Beijing after the United States rejected China’s claims to offshore resources in most of the South China Sea. Adding salt to the wound, British Prime Minister Boris Johnson ordered equipment of the world’s biggest telecoms equipment maker, Huawei, to be purged completely from Britain’s 5G network by 2027.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X